- Investing Ideas
- /
- Danish Solid Balance Sheet and Fundamentals
Danish Solid Balance Sheet and Fundamentals
Results
5
High return on equity, past performance and sound balance sheet.
5 companies
ChemoMetec
Market Cap: DKK 9.1b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 521.00
7D
-1.0%
1Y
39.1%
Genmab
Market Cap: DKK 99.2b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,588.00
7D
1.1%
1Y
-15.2%
Gubra
Market Cap: DKK 6.3b
A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.
GUBRA
DKK 375.20
7D
0.6%
1Y
-33.9%
Zealand Pharma
Market Cap: DKK 31.1b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 438.50
7D
5.3%
1Y
-50.5%
Dataproces Group
Market Cap: DKK 243.5m
Provides IT and consulting services for municipalities in Denmark.
DATA
DKK 7.24
7D
-1.4%
1Y
40.6%